QUREuniQure N.V.

$1B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+11.2% YoY

Gross Profit

-$34M-1710.8% margin

Operating Income

-$45M-2262.4% margin

Net Income

-$37M-1836.7% margin

EPS (Diluted)

$-0.79

QoQ Revenue Growth

-99.6%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$48M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$775M

Total Liabilities

$184M

Stockholders' Equity

$591M

Cash & Equivalents

$578M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+11.2%
Gross Profit	-$34M	$2M	-2002.0%
Operating Income	-$45M	-$44M	-1.1%
Net Income	-$37M	-$54M	+32.1%

Revenue Segments

Collaborative Revenue

$2M100%

QURE Q3 2021 Earnings — uniQure N.V. Revenue & Financial Results | Market Cap Arena